Michael David Garrison - 15 Jan 2026 Form 4 Insider Report for BECTON DICKINSON & CO (BDX)

Reporting relationship: EVP & Pres Med.Essntl&BioPharm
Issuer ticker: BDX
Reported as of: 15 Jan 2026
Net transaction value: -$334,094
SEC form: 4
Accepted by SEC: 16 Jan 2026, 15:43:46 UTC
Prior SEC filing: 17 Dec 2025
Next SEC filing: 11 Jun 2026
Source filing: View source filing
Reporting owner signature: Donna Kalazdy, by power of attorney from Michael David Garrison

Key filing fact

Michael David Garrison filed Form 4 for BECTON DICKINSON & CO (BDX) on 16 Jan 2026.

Key facts

This page summarizes Michael David Garrison's Form 4 filing for BECTON DICKINSON & CO (BDX).
5 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 16 Jan 2026, 15:43.

Change

Previous filing in this sequence was filed on 17 Dec 2025.
Current net transaction value: -$334,094.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001944816 Primary reporting owner

Garrison Michael David

Relationship: EVP & Pres Med.Essntl&BioPharm
Address: C/O BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES
Signature: Donna Kalazdy, by power of attorney from Michael David Garrison
Signature date: 16 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BDX transaction

Common Stock

Options Exercise

Transaction value: $512,797
Shares: +3,054
Change %: +23%
Price: $167.91
Shares after: 16,159
Date: 15 Jan 2026
Ownership: Direct

BDX transaction

Common Stock

Disposed to Issuer

Transaction value: $512,886
Shares: -2,454
Change %: -15%
Price: $209.00
Shares after: 13,705
Date: 15 Jan 2026
Ownership: Direct

BDX transaction

Common Stock

Sale

Transaction value: $125,400
Shares: -600
Change %: -4.4%
Price: $209.00
Shares after: 13,105
Date: 15 Jan 2026
Ownership: Direct

BDX transaction

Common Stock

Sale

Transaction value: $208,605
Shares: -1,010
Change %: -7.7%
Price: $206.54
Shares after: 12,095
Date: 15 Jan 2026
Ownership: Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BDX transaction Derivative

Stock Appreciation Rights

Options Exercise

Transaction value: $0
Shares: -3,054
Change %: -100%
Price: $0.000000
Shares after: 0
Date: 15 Jan 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 3,054
Exercise price: $167.91
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

The stock appreciation rights vested in four annual installments beginning one year from the grant date.

SEC remarks

The reported transactions were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 13, 2025.